Bacteriophage Applications Historical Perspective And Future Potential
Bacteriophage Applications Historical Perspective And Future Potential Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Bacteriophage Applications Historical Perspective And Future Potential book. This book definitely worth reading, it is an incredibly well-written.
Bacteriophage Applications - Historical Perspective and Future Potential by Jessica Nicastro,Shirley Wong,Zahra Khazaei,Peggy Lam,Jonathan Blay,Roderick A. Slavcev Pdf
This book explores key applications of phage biotechnology and reviews recent advances in phage display technologies. The applications covered were selected on the basis of their significance and representativeness in the field. The small size and enormous diversity of bacteriophages make them ideal candidates for numerous applications across many industries. Since the discovery of phages and the advent of phage display systems, considerable attention has been focused on the development of novel therapeutic and industrial applications. Recent studies combine the genomic flexibility of phages with phage display systems in order to generate modified phages for targeted delivery.
Phage Therapy: Past, Present and Future by Stephen T. Abedon,Pilar García,Peter Mullany,Rustam Aminov Pdf
Historically, the first observation of a transmissible lytic agent that is specifically active against a bacterium (Bacillus anthracis) was by a Russian microbiologist Nikolay Gamaleya in 1898. At that time, however, it was too early to make a connection to another discovery made by Dmitri Ivanovsky in 1892 and Martinus Beijerinck in 1898 on a non-bacterial pathogen infecting tobacco plants. Thus the viral world was discovered in two of the three domains of life, and our current understanding is that viruses represent the most abundant biological entities on the planet. The potential of bacteriophages for infection treatment have been recognized after the discoveries by Frederick Twort and Felix d’Hérelle in 1915 and 1917. Subsequent phage therapy developments, however, have been overshadowed by the remarkable success of antibiotics in infection control and treatment, and phage therapy research and development persisted mostly in the former Soviet Union countries, Russia and Georgia, as well as in France and Poland. The dramatic rise of antibiotic resistance and especially of multi-drug resistance among human and animal bacterial pathogens, however, challenged the position of antibiotics as a single most important pillar for infection control and treatment. Thus there is a renewed interest in phage therapy as a possible additive/alternative therapy, especially for the infections that resist routine antibiotic treatment. The basis for the revival of phage therapy is affected by a number of issues that need to be resolved before it can enter the arena, which is traditionally reserved for antibiotics. Probably the most important is the regulatory issue: How should phage therapy be regulated? Similarly to drugs? Then the co-evolving nature of phage-bacterial host relationship will be a major hurdle for the production of consistent phage formulae. Or should we resort to the phage products such as lysins and the corresponding engineered versions in order to have accurate and consistent delivery doses? We still have very limited knowledge about the pharmacodynamics of phage therapy. More data, obtained in animal models, are necessary to evaluate the phage therapy efficiency compared, for example, to antibiotics. Another aspect is the safety of phage therapy. How do phages interact with the immune system and to what costs, or benefits? What are the risks, in the course of phage therapy, of transduction of undesirable properties such as virulence or antibiotic resistance genes? How frequent is the development of bacterial host resistance during phage therapy? Understanding these and many other aspects of phage therapy, basic and applied, is the main subject of this Topic.
Bacteriophages are viruses that utilise bacterial cells as factories for their own propagation and as safe havens for their genomic material. They are capable of equipping bacteria with properties that bestow environmental advantages. They are also capable of specifically and efficiently killing bacteria.Bacteriophages are resilient in a wide diversity of environments, presumed to be as ancient as life itself, and are estimated to be the most numerous biological entities on the planet. Their overarching capacity to survive via molecular adaptation is supported by an arsenal of encoded enzymatic tools, which also enabled biotechnology. This volume includes contributions that describe bacteriophages as nanomachines, genetic engineers, and also as medicines and technologies of the future, including relevant production and process issues.
This book fills a void. Never before has a comprehensive history of phage therapy—a once-neglected, now resurgent field—been written. Kuchment writes from the perspective of the eager student of history for the common reader.
Advances in Phage Therapy: Present Challenges and Future Perspectives by Andrzej Gorski,Petar Knezevic,Naomi Sulinger Hoyle,Shigenobu Matsuzaki Pdf
This Research Topic is dedicated to Prof. Elisabeth Kutter on the occasion of her 80th birthday. Dr. Kutter’s career as a phage scientist has extended nearly 60 years. She has been a pioneer as a woman in science. She started to work with phage at the University of Rochester, New York working with Dr. Wiberg on radioisotopes making excellent progress in the field – progress which was even cited in Luria’s 1969 Nobel Prize talk. Betty first encountered phage therapy during a visit to Georgia in 1990 which was part of a longer stay in the former Soviet Union under a US-USSR research exchange program. Dr. Kutter was one of the first Americans to advocate for phage therapy in the post antibiotic era. Betty started hosting the Evergreen International Phage meetings in Olympia, Washington, from 1975 onward, which helped to develop a strong phage community with participation increasing over the years to 350 at the 23 rd biannual last year. Betty continues to be an active member in the phage community, sharing her experience and working with all of us toward her ultimate goal of making phage therapy available worldwide thus reducing the burden caused by antibiotic resistant bacterial infections.
Biological Treatment of Microbial Corrosion by Reza Javaherdashti,Kiana Alasvand Pdf
Biological Treatment of Microbial Corrosion: Opportunities and Challenges explores the latest biological approaches to microbial corrosion and its inhibition. The book provides comprehensive information on the current knowledge of microbes involved in corrosion and their mechanisms of action on corrosion induction and inhibition. This information is helpful for a wide range of audiences, from university researchers, to industry specialists. The book discusses foundational information about corrosion and microbiologically influenced corrosion and its importance. Other chapters provide an in-depth review of corrosion causing microorganisms, their properties and their mechanism of involvement in MIC. Updated findings on the biological treatment of corrosion are addressed, as are future opportunities and challenges that could lead to prosperous, sustainable and secure industrial application of these techniques. Provides a detailed overview of the fundamental concepts of corrosion Discusses MIC, including its characteristics, properties and modelling Previews the opportunities and challenges faced by the utilization of biological treatments for corrosion
A Literature Review of the Practical Application of Bacteriophage Research by Nina Chanishvili Pdf
Bacteriophage is a live micro-organism, a natural enemy of bacteria. Canadian microbiologist Felix d'Herelle proposed that bacteriophage might be applied to the control of bacterial diseases, however in the West this idea was not explored with the same enthusiasm as in the former Soviet Union and was eventually discarded with the arrival of antibiotics. Phage therapy is successfully used for the treatment of a wide spectrum of bacterial infections. Such experience has now become extremely important with the rapidly-increasing spread of antibiotic-resistant bacterial infections which are almost impossible to overcome these days. Phage therapy has been considered as an alternative to antibiotic- therapy and it is now attracting global interest. Most of the scientific works in phage therapy were published in Russian and are thus not easily available in the West. This fact inspired the authors to write a book based on the historical publications found in the library of the Eliava Institute.
Recent Advances in the Application of Marine Natural Products as Antimicrobial Agents by Arumugam Veera Ravi,Ramanathan Srinivasan,Arunachalam Kannappan Pdf
While the world is grappling with the growing problem of antibiotic resistance, marine organisms offer a promising solution with their diverse repertoire of bioactive compounds. This thematic volume explores the untapped potential of marine organisms in the fight against microbial threats. The focus of the 17 featured chapters lies in highlighting the vast array of antimicrobial agents that can be found within marine environments. The chapters provide in-depth knowledge about the latest discoveries, advancements and future needs in antimicrobial research. Readers will learn about astonishing discoveries of natural compounds with remarkable antimicrobial properties and sources. The list of agents covered in the book includes synthetic derivatives, bioactive polysaccharides and marine viruses. The book also includes chapters that cover various stages of the antimicrobial drug development process, providing an overview of recent antimicrobial agents derived from marine organisms, preclinical studies and the identification of patented drugs sourced from the ocean. Furthermore, the book sheds light on the diverse applications of these marine-derived compounds, spanning the fields of medicine, agriculture, and industry. Professionals in the fields of microbiology, marine biology, pharmaceutical sciences, and drug development will gain valuable insights into the use of marine organisms as a source of antimicrobial agents. Audience Medicinal chemists, professional researchers and scholars in microbiology, marine biology and related fields in life sciences.
Microbial Biotechnology: Basic Research and Applications by Joginder Singh,Ashish Vyas,Shanquan Wang,Ram Prasad Pdf
Microbial biotechnology is an important area that promotes advanced research into using microbes for value-added products, human nutrition, and the overall wellbeing of society. This book presents the latest information on the use of microbes for sustainable development, and highlights state-of-the-art biotechnological techniques used to harness microbial biotechnological traits on a commercial scale. Gathering contributions from authoritative researchers in the field, it addresses recent advances in microbial biotechnological approaches that offer sustainable options for future generations. Exploring a broad range of microbial products and their uses, the book specifically places emphasis on the application of microorganisms in healthcare, the environment and industry. It also discusses various compound classes derived from microbial metabolites. Pursuing a holistic approach to recent advances in the utilization of various microbes as biotechnological tools, the book also covers traditional uses, and explores emerging strategies to harness their full potential. Accordingly, it offers a valuable resource for researchers and graduate students alike.
Advances in Applied Microbiology by Geoffrey M. Gadd,Sima Sariaslani Pdf
Advances in Applied Microbiology, Volume 113, continues the comprehensive reach of this widely read and authoritative review source in microbiology. Users will find invaluable references and information on a variety of areas relating to the topic, with this release focusing on Gaps in the Assortment of Rapid Assays for Microorganisms of Interest to the Dairy Industry, Metal reduction and corrosion by bacterial biofilms, The microbiology of red brines, Clostridium thermocellum: a microbial platform for high-value chemical production from lignocellulose, and The zincophore system in pathogenic yeasts. Contains contributions from leading authorities in the field Informs and updates on all the latest developments in the field of microbiology Includes discussions on the role of specific molecules in pathogen life stages, interactions, and much more
Hurdles for Phage Therapy (PT) to Become a Reality by Harald Brüssow Pdf
Alternative treatment modes for antibiotic-resistant bacterial pathogens have become a public health priority. Bacteriophages are bacterial viruses that infect and lyse bacterial cells. Since bacteriophages are frequently bacterial host species-specific and can often also infect antibiotic-resistant bacterial cells, they could represent ideal antimicrobials for fighting the antibiotic resistance crisis. The medical use of bacteriophages has become known as phage therapy. It is widely used in Russia, where phage cocktails are sold in pharmacies as an over-the-counter drug. However, no phage product has been registered for medical purposes outside of the former Soviet Union. The current Special Issue of Viruses contains a collection of papers from opinion leaders in the field who explore hurdles to the introduction of phage therapy in western countries. The articles cover diverse topics ranging from patent to regulatory issues, the targeting of suitable bacterial infections, and the selection and characterization of safe and efficient phage cocktails. Phage resistance is discussed, and gaps in our knowledge of phage–bacterium interactions in the mammalian body are revealed, while other articles explore the use of phages in food production and processing.
Bacteriophages in Health and Disease by Paul Hyman,Stephen T. Abedon Pdf
Bacteriophages are viruses that infect bacteria; as such, they have many potential uses for promoting health and combating disease. This book covers the many facets of phage-bacterial-human interaction in three sections: the role and impact of phages on natural bacterial communities, the potential to develop phage-based therapeutics and other aspects in which phages can be used to combat disease, including bacterial detection, bacterial epidemiology, the tracing of fecal contamination of water and decontamination of foods.
Aquaculture production is expanding worldwide in both volume and scope, with a number of new species being introduced to aquaculture every year. Salmon Farming provides an overview of aquaculture production systems focusing on Atlantic salmon farming, which will enable users to: produce broodstock, juveniles and adult fish develop a production plan for juvenile and ongrowing farms evaluate and optimize the key working operations on juvenile and ongrowing farms identify the factors that are important for economic and sustainable production identify the factors that affect the rate of production, how these factors can be changed, and what effects such changes have adopt the best procedures for season-independent smolt production understand water quality requirements and evaluate the suitability based on water analysis prepare documents for production control and propose amendments prepare working plans for smolt production and ongrowing production farms establish maintenance routines/plans for smolt production and ongrowing production estimate the investment and running cost for the main components of smolt and ongrowing farms remain up to date with the laws and regulations that need to be considered in aquaculture production planning internationally stay abreast of new trends in the industry. Salmon Farming gives an overview of aquaculture production systems focusing on Atlantic salmon farming. However, much of the subject coverage and overall structure of the book are directly transferable to other species, with much of the core of the book being species-independent and applicable internationally. 5m Books
Deliberately breaking with the classical biology-centered description of marine organisms and their products, this reference emphasizes microbial technology over basic biology, setting it apart from its predecessors. As such, it systematically covers the technology behind high-value compounds for use as pharmaceuticals, nutraceuticals or cosmetics, from prospecting to production issues. Following a definition of the field, the book goes on to address all industrially important aspects of marine microbial biotechnology. The first main part contains a description of the major production organisms, from archaebacteria to cyanobacteria to algae and symbionts, including their genetic engineering. The remaining four parts look at commercially important compounds produced by these microorganisms together with their applications. Throughout, the emphasis is on technological considerations, and the future potential of these organisms or compound classes is discussed. A valuable and forward-looking resource for innovative biotechnologists in industry as well as in academia.